These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]
8. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy. Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR; Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596 [TBL] [Abstract][Full Text] [Related]
9. Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients. Tcheng JE; Mackay SM Am J Cardiovasc Drugs; 2012 Apr; 12(2):83-91. PubMed ID: 22316323 [TBL] [Abstract][Full Text] [Related]
10. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials. Mariani M; Mariani G; De Servi S Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763 [TBL] [Abstract][Full Text] [Related]
12. Ticagrelor: a novel reversible oral antiplatelet agent. Nawarskas JJ; Clark SM Cardiol Rev; 2011; 19(2):95-100. PubMed ID: 21285670 [TBL] [Abstract][Full Text] [Related]
13. Prasugrel: Clinical development and therapeutic application. Guerra DR; Tcheng JE Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231 [TBL] [Abstract][Full Text] [Related]
14. Clopidogrel, prasugrel, or ticagrelor? a practical guide to use of antiplatelet agents in patients with acute coronary syndromes. Norgard NB; Dinicolantonio JJ Postgrad Med; 2013 Jul; 125(4):91-102. PubMed ID: 23933898 [TBL] [Abstract][Full Text] [Related]
15. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology. Clemmensen P; Dridi NP; Holmvang L Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983 [TBL] [Abstract][Full Text] [Related]
16. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome. Packard KA; Campbell JA; Knezevich JT; Davis EM Pharmacotherapy; 2012 Mar; 32(3):244-73. PubMed ID: 22392457 [TBL] [Abstract][Full Text] [Related]
17. Ticagrelor for acute coronary syndrome? Drug Ther Bull; 2011 Jun; 49(6):66-8. PubMed ID: 21632607 [TBL] [Abstract][Full Text] [Related]
18. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678 [TBL] [Abstract][Full Text] [Related]
19. Acute coronary syndromes: identifying the appropriate patient for prasugrel. Stephens JC; Askari AT Postgrad Med; 2012 Mar; 124(2):16-28. PubMed ID: 22437212 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet therapy in patients with ST-elevation myocardial infarction undergoing myocardial revascularisation: beyond clopidogrel. Wouter Jukema J; Collet JP; De Luca L Curr Med Res Opin; 2012 Feb; 28(2):203-11. PubMed ID: 22181345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]